Variant report
Variant | nsv522141 |
---|---|
Chromosome Location | chr8:107502431-107506303 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs16874737 | chr8:107502431-107502432 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
2 | rs569188740 | chr8:107502446-107502447 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs536013525 | chr8:107502516-107502517 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs368438370 | chr8:107502531-107502532 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs148049476 | chr8:107502571-107502572 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs371449333 | chr8:107502572-107502573 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs536545989 | chr8:107502616-107502617 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs145100444 | chr8:107502636-107502637 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs80068356 | chr8:107502659-107502660 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs556019456 | chr8:107502672-107502673 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs533870067 | chr8:107502703-107502704 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs558258622 | chr8:107502712-107502713 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs576426687 | chr8:107502736-107502737 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs112790932 | chr8:107502752-107502753 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs35962351 | chr8:107502768-107502769 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs555008393 | chr8:107502835-107502836 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs543844341 | chr8:107502857-107502858 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs2444321 | chr8:107502893-107502894 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
19 | rs538645321 | chr8:107502916-107502917 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs575894605 | chr8:107502924-107502925 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs542822515 | chr8:107502938-107502939 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs2510829 | chr8:107502955-107502956 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
23 | rs181687522 | chr8:107502965-107502966 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs540730258 | chr8:107502971-107502972 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs565420597 | chr8:107502984-107502985 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs532509648 | chr8:107503035-107503036 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs550998901 | chr8:107503080-107503081 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs72680913 | chr8:107503089-107503090 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
29 | rs3018081 | chr8:107503090-107503091 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
30 | rs575859210 | chr8:107503091-107503092 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs566637431 | chr8:107503092-107503093 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs76175850 | chr8:107503119-107503120 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs551845552 | chr8:107503188-107503189 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs570220635 | chr8:107503236-107503237 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs537399759 | chr8:107503247-107503248 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs146890580 | chr8:107503274-107503275 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs575810320 | chr8:107503316-107503317 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs536933479 | chr8:107503332-107503333 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs140714925 | chr8:107503342-107503343 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs540840829 | chr8:107503396-107503397 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs532537114 | chr8:107503438-107503439 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs145848561 | chr8:107503440-107503441 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs138151064 | chr8:107503552-107503553 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs544583510 | chr8:107503579-107503580 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs562884858 | chr8:107503587-107503588 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs76595317 | chr8:107503593-107503594 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs543716438 | chr8:107503646-107503647 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs559385677 | chr8:107503696-107503697 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs188663049 | chr8:107503699-107503700 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs560227529 | chr8:107503730-107503731 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Melanoma | 18172304 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Autism | 19415332 | CNVD |
Malaria | 21533027 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Gastric cancer | 17908304 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Breast cancer | 21245420 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Liver carcinoma | 19366792 | CNVD |
Seminomas | 18059402 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Pancreatic cancer | 21811587 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Breast cancer | 17603634 | CNVD |
Testicular cancer | 18059402 | CNVD |
Breast cancer | 17133270 | CNVD |
Breast cancer | 21509527 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Breast cancer | 21858162 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Acute lymphoblastic leukemia | 21248843 | CNVD |
Cancer | 20164919 | CNVD |
abnormal development | 18461090 | CNVD |
Oral cancer | 21386901 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Langer-Giedion syndrome | 22283845 | CNVD |
Cancer | 21637783 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Breast cancer | 20632083 | CNVD |
Breast cancer | 19602461 | CNVD |
Cancer | 22429812 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Oral cancer | 19627613 | CNVD |
Prostate cancer | 21088497 | CNVD |
colon cancer | 17210682 | CNVD |
Breast cancer | 21264507 | CNVD |
Breast cancer | 22028636 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Cancer | 16751803 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Gastric cancer | 17167181 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Breast cancer | 16461572 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Medulloblastoma | 16968546 | CNVD |
head and neck squamous cell carcinoma | 18028549 | CNVD |
Breast cancer | 17001317 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Lung cancer | 18438408 | CNVD |
Breast cancer | 16608533 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Hepatocellular carcinoma | 18803288 | CNVD |
Prostate cancer | 18632612 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Prostate cancer | 16573809 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Carcinoma ex pleomorphic adenoma | 18828159 | CNVD |
Adenocarcinoma | 21044232 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Prostate cancer | 16461572 | CNVD |
Breast cancer | 21399628 | CNVD |
small cell lung cancer | 20016488 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Breast cancer | 17393978 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Non-syndromic sensorineural hearing loss | 20606397 | CNVD |
Breast cancer | 17899364 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Colorectal cancer | 16774939 | CNVD |
Autosomal-dominant progressive external ophthalmoplegia | 19664747 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Congenital diaphragmatic hernia | 21085971 | CNVD |
Multiple myeloma | 16461302 | CNVD |
Sezary syndrome | 18413736 | CNVD |
Breast cancer | 21611746 | CNVD |
Developmental delay | 21147756 | CNVD |
Congenital diaphragmatic hernia | 21525063 | CNVD |
Breast cancer | 21364760 | CNVD |
Gastric cancer | 22539939 | CNVD |
Non-small cell lung cancer | 19010865 | CNVD |
Prostate cancer | 22341455 | CNVD |
Colorectal cancer | 21645411 | CNVD |
Multiple myeloma | 17550852 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr8:107475400-107511600 | Weak transcription | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
2 | chr8:107502800-107503400 | Enhancers | Cortex derived primary cultured neurospheres | brain |
3 | chr8:107503000-107503400 | Enhancers | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
4 | chr8:107503000-107503400 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
5 | chr8:107503400-107503800 | Weak transcription | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
6 | chr8:107503600-107513400 | Weak transcription | Spleen | Spleen |
7 | chr8:107503800-107504000 | Enhancers | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
8 | chr8:107504000-107513400 | Weak transcription | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
9 | chr8:107504200-107507000 | Weak transcription | Primary T killer naive cells fromperipheralblood | blood |
10 | chr8:107505200-107505800 | Enhancers | iPS-20b Cell Line | embryonic stem cell |
11 | chr8:107505800-107513400 | Weak transcription | iPS-20b Cell Line | embryonic stem cell |
12 | chr8:107506200-107511600 | Weak transcription | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |